These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8042218)

  • 1. Mechanisms of vasodilation of cerebral vessels induced by the potassium channel opener nicorandil in canine in vivo experiments.
    Ishiyama T; Dohi S; Iida H; Akamatsu S; Ohta S; Shimonaka H
    Stroke; 1994 Aug; 25(8):1644-50. PubMed ID: 8042218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K; Yamada H; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery.
    Ogawa N; Fukata Y; Kaneta S; Jinno Y; Miwa A; Fukushima H
    Jpn J Pharmacol; 1993 Apr; 61(4):303-9. PubMed ID: 8320876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mild hypothermia on nicorandil-induced vasodilation of pial arterioles in cats.
    Inoue S; Kawaguchi M; Kurehara K; Sakamoto T; Kitaguchi K; Furuya H
    Crit Care Med; 2001 Nov; 29(11):2162-8. PubMed ID: 11700414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
    Holzmann S; Kukovetz WR; Braida C; Pöch G
    Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
    Imagawa J; Akima M; Nabata H; Taira N
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
    Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner.
    Satoh K; Mori T; Yamada H; Taira N
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):691-9. PubMed ID: 8241013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
    Kreye VA; Lenz T; Theiss U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim.
    Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D
    Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T; Teshigawara T; Taira N
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
    Kreye VA; Lenz T; Pfründer D; Theiss U
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
    Yoneyama F; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vascular effects of topical and intravenous alpha2-adrenoceptor agonist clonidine on canine pial microcirculation.
    Ishiyama T; Dohi S; Iida H
    Anesth Analg; 1998 Apr; 86(4):766-72. PubMed ID: 9539599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicorandil protects pial arterioles from endothelial dysfunction induced by smoking in rats.
    Iwata K; Iida H; Iida M; Takenaka M; Tanabe K; Fukuoka N; Uchida M
    J Neurosurg Anesthesiol; 2013 Oct; 25(4):392-8. PubMed ID: 23660509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
    Abe S; Nishimura J; Nakamura M; Kanaide H
    J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.